ENG/中
老虎證券
行情
交易
收费
优惠与活动
帮助
TigerAI
专栏
关于
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Orexigen Therapeutics
0.2229
0.0000
成交量：
- -
成交額：
- -
市值：
420.99萬
市盈率：
-0.02
高：
0.2229
開：
0.2229
低：
0.2229
收：
0.2229
52周最高：
3.81
52周最低：
0.1708
股本：
1,888.70萬
流通股本：
967.74萬
量比：
- -
換手率：
- -
股息：
- -
股息率：
- -
每股收益(TTM):
-9.7006
淨資產收益率：
--
總資產收益率：
--
市淨率：
-0.07
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字：
Orexigen Therapeutics
交易所：
NASDAQ
成立時間：
- -
員工人數：
- -
公司地址：
- -
官網：
http://www.orexigen.com
郵編：
- -
電話：
- -
傳真：
- -
簡介：
Orexigen Therapeutics, Inc.於2002年9月在特拉華成立。Orexigen治療股份有限公司是一家生物製藥公司，專註於發展治療肥胖的候選醫藥產品。公司的主導產品有針對肥胖者的已完成三期臨床試驗的納曲酮和已完成二期臨床試驗的empati。納曲酮是兩個行之有效的藥物的組合，包括安非他酮，納曲酮。安非他酮是一種廣泛應用的抗抑鬱藥和戒煙藥物；納曲酮用於酒精和阿片成癮治療。Empatic的組合是安非他酮和唑尼沙胺，唑尼沙胺立即釋放製劑在美國被批准用於部分癲癇發作的輔助治療。每個候選產品在商業化之前都將獲得監管機構的批准。公司在努力的向監管機構證明這些組合的療效和安全性，以獲得批准。
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/OREX/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"OREX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OREX\",,,,,undefined,":{"symbol":"OREX","market":"US","secType":"STK","nameCN":"Orexigen Therapeutics","latestPrice":0.2229,"timestamp":1522785600000,"preClose":0.2229,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":9677447,"shares":18887033,"eps":-9.700626,"marketStatus":"退市","change":0,"latestTime":"02-24 07:36:47 EST","open":0.2229,"high":0.2229,"low":0.2229,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-9.700626,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1771943400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1177560000000,"exchange":"NASDAQ","adjPreClose":0.2229,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OREX\",,,,,undefined,":{"symbol":"OREX","floatShares":9677447,"roa":"--","roe":"--","lyrEps":0,"shares":18887033,"dividePrice":0,"high":0.2229,"amplitude":0,"preClose":0.2229,"low":0.2229,"week52Low":0.1708,"pbRate":"-0.07","week52High":3.805,"institutionHeld":0.9018,"latestPrice":0.2229,"eps":-9.700626,"divideRate":0,"volume":0,"delay":0,"ttmEps":-9.700626,"open":0.2229},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OREX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2017-11-13","symbol":"OREX","fiscalQuarterEnding":"2017/09","expectedEps":-2.13,"name":null,"time":"盤後","type":"earning","dateTimestamp":1510549200000,"reportTimeType":"post","actualEps":-1.35},{"market":"US","date":"2017-08-08","symbol":"OREX","fiscalQuarterEnding":"2017/06","expectedEps":-2.4,"name":null,"time":"盤後","type":"earning","dateTimestamp":1502164800000,"reportTimeType":"post","actualEps":-1.82},{"market":"US","date":"2017-05-09","symbol":"OREX","fiscalQuarterEnding":"2017/03","expectedEps":-2.6,"name":null,"time":"盤後","type":"earning","dateTimestamp":1494302400000,"reportTimeType":"post","actualEps":-4.67},{"market":"US","date":"2017-03-28","symbol":"OREX","fiscalQuarterEnding":"2016/12","expectedEps":-0.54,"name":null,"time":"盤前","type":"earning","dateTimestamp":1490673600000,"reportTimeType":"pre","actualEps":-2.67},{"market":"US","date":"2016-11-03","symbol":"OREX","fiscalQuarterEnding":"2016/09","expectedEps":-2.13,"name":null,"time":"盤後","type":"earning","dateTimestamp":1478145600000,"reportTimeType":"post","actualEps":-1.01}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OREX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OREX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.orexigen.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0009},{"period":"1month","weight":-0.0099},{"period":"3month","weight":0.0109},{"period":"6month","weight":0.0553},{"period":"1year","weight":0.1374},{"period":"ytd","weight":0.0007}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Orexigen Therapeutics, Inc.於2002年9月在特拉華成立。Orexigen治療股份有限公司是一家生物製藥公司，專註於發展治療肥胖的候選醫藥產品。公司的主導產品有針對肥胖者的已完成三期臨床試驗的納曲酮和已完成二期臨床試驗的empati。納曲酮是兩個行之有效的藥物的組合，包括安非他酮，納曲酮。安非他酮是一種廣泛應用的抗抑鬱藥和戒煙藥物；納曲酮用於酒精和阿片成癮治療。Empatic的組合是安非他酮和唑尼沙胺，唑尼沙胺立即釋放製劑在美國被批准用於部分癲癇發作的輔助治療。每個候選產品在商業化之前都將獲得監管機構的批准。公司在努力的向監管機構證明這些組合的療效和安全性，以獲得批准。","exchange":"NASDAQ","name":"Orexigen Therapeutics","nameEN":"Orexigen Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"OREX\",market:\"US\",,,undefined,":null}}